AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Lifecare ASA

Report Publication Announcement Nov 6, 2025

3654_rns_2025-11-06_6f4538c3-ea0d-43da-9dbe-14cfa045a6bc.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

Lifecare ASA (LIFE): Invitation to presentation of Q3 2025 results

Lifecare ASA (LIFE): Invitation to presentation of Q3 2025 results

Lifecare ASA will release its results for the third quarter of 2025 on

Wednesday, 12 November 2025 at 07:00 a.m. CET. The company will host a

presentation of the results at 10:00 a.m. the same day.

Lifecare ASA hereby invites you to the presentation of the third quarter 2025

results.

Date: Wednesday 12 November

Time: 10:00 a.m. CET

The results will be presented in English and broadcast live via webcast,

followed by a Q&A session. Participants will be able to submit questions

online throughout the session.

To access the webcast Join the Teams-meeting here.

(https://eur04.safelinks.protection.outlook.com/ap/t-59584e83/?url=https%3A%2F%2Fteams.microsoft.com%2Fl%2Fmeetup-join%2F19%253ameeting_MjhiMDliMmUtZmU3YS00MmQ3LWFmZjAtMjFkYTM2ODA4NzJi%2540thread.v2%2F0%3Fcontext%3D%257b%2522Tid%2522%253a%252210b30f00-1bbd-4041-9c4d-64749f4a7041%2522%252c%2522Oid%2522%253a%25223758e62c-12e5-4419-a645-4b77ef5225be%2522%257d&data=05|02|asle.wingsternes%40lifecare.no|02ab5775069c4453b5b308de187b70da|c5fbb1c64eb045db9f3c6e20ebcd710e|0|0|638975115642037858|Unknown|TWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D|0|||&sdata=H%2B69p81%2FuJ%2FRcOUfC%2FO9leLDEu9GxppO%2FQ7q47qgW6M%3D&reserved=0)

A recording of the webcast will be available on our website after the event.

About us

Lifecare ASA is a medical sensor company developing technology for sensing and

monitoring of various body analytes. Lifecare's focus is to bring the next

generation of Continuous Glucose Monitoring systems to market. Lifecare

enables osmotic pressure as sensing principle. Lifecare's sensor technology is

suitable for identifying and monitoring the occurrence of a wide range of

analytes and molecules in the human body and in pets.

Contacts

For further information, please contact:

Joacim Holter, CEO, [email protected], +47 40 05 90 40

Renete Kaarvik, CFO, [email protected], +47 94 83 82 42

Talk to a Data Expert

Have a question? We'll get back to you promptly.